This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/1/2024
during the question and answer session. Please note today's call will be recorded and I will be standing by should you need any assistance. It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Please go ahead.
Thank you, Chloe. Welcome to Nurocrine Biosciences second quarter 2024 earnings call. With me are Kevin Gorman, our current Chief Executive Officer. Matt Abernathy, Chief Financial Officer.
Ivory Roberts, Chief Medical Officer. Eric Berger, Chief Financial Officer. Eric Berger, Chief Financial Officer.
You're reading a preview of the NBIX Q2 2024 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing